VSTM.NASDAQVerastem, INC

Form 4: Verastem Director Anil Kapur Acquires 36,000 RSUs

Sentiment:

Statement of Changes in Beneficial Ownership


Verastem, Inc. reports that Director Anil Kapur acquired 36,000 Restricted Stock Units (RSUs) on May 21, 2026, as part of his compensation under the company's equity incentive plan.

Summary

  • Director Anil Kapur was granted 36,000 Restricted Stock Units (RSUs) on May 21, 2026.
  • These RSUs are part of the Verastem, Inc. Amended and Restated 2021 Equity Incentive Plan.
  • Each RSU represents the right to receive one share of Common Stock.
  • The RSUs will vest in twelve installments, starting from June 2026 through May 2027, contingent on Kapur's continued service as a director.
  • Following this grant, Kapur beneficially owns 52,666 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily details routine compensation for a director rather than significant financial or strategic developments.

Positives

  • Director Anil Kapur received a significant grant of 36,000 RSUs, indicating continued investment in the company's long-term success.
  • The vesting schedule over twelve months suggests a commitment to retaining key leadership.
  • The grant is part of a formal equity incentive plan, aligning management's interests with shareholders.

Negatives

  • The filing does not disclose any negative financial or operational information.

Risks

  • The vesting of RSUs is contingent on the Reporting Person continuing to serve as a director, implying a risk of forfeiture if service is terminated before vesting.
  • The value of the RSUs is tied to the performance of Verastem, Inc.'s common stock, which is subject to market volatility.

Future Outlook

The vesting schedule for the RSUs indicates a forward-looking commitment from Director Anil Kapur, with vesting occurring over a period extending into May 2027.

Industry Context

StockSavvy.ai notes that grants of Restricted Stock Units (RSUs) are a common form of executive and director compensation in the biotechnology and pharmaceutical sectors, used to incentivize long-term performance and retention.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Equity Incentive PlanGrant of RSUs under the Issuer's Amended and Restated 2021 Equity Incentive Plan.05/21/2026Standard practice for aligning director compensation with company performance and retention.

Related Party Transactions

  • The acquisition of 36,000 RSUs by Director Anil Kapur is a related party transaction, as it involves compensation to a company insider.

Stakeholder Impact

  • Shareholders: The RSU grant aligns director incentives with long-term shareholder value, but the dilution from future share issuance upon vesting should be considered.
  • Employees: This filing does not directly impact employees, but it reflects the company's compensation structure for its board.
  • Management: Reinforces the compensation structure for directors within the company's equity incentive framework.

Next Steps

  • Vesting of RSUs in twelve installments from June 2026 to May 2027, contingent on continued directorship.
  • Reporting Person Anil Kapur will continue to serve as a director of Verastem, Inc.

Key Dates

DateDescription
05/21/2026Transaction Date for RSU grant
06/30/2026First installment vesting date for RSUs
05/31/2027Final vesting date for RSUs (or earlier if 2027 Annual Meeting occurs prior)

Keywords

Verastem, VSTM, Form 4, Anil Kapur, Director, RSU, Restricted Stock Units, Equity Incentive Plan, Beneficial Ownership, Securities Exchange Act

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.